Rockwell Medical Technologies (RMTI) Misses Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts RMTI Hot Sheet
Price: $8.70 +7.81%
Revenue Growth %: +14.9%
Financial Fact:
Operating Income (Loss): -4.75M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Revenue Growth %: +14.9%
Financial Fact:
Operating Income (Loss): -4.75M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
Rockwell Medical Technologies (NASDAQ: RMTI) reported Q2 EPS of ($0.11), $0.01 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $13.5 million versus the consensus estimate of $13.86 million.
For earnings history and earnings-related data on Rockwell Medical Technologies (RMTI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- UBS Downgrades Buzzi Unicem SpA (BZU:IM) (BZZUY) to Sell
- Credo Technology shares rise on analyst support and conference comments
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
